Researchers
have been putting up fliers around college campuses and city centers to
get people to participate in medical studies for decades. But the
methods for obtaining this type of quantitative data has always been a
challenge and has been largely unchanged.
But now Apple is involved.
See also: Ahead of the Apple Watch, smartwatch makers are learning to put fashion first
As
a part of a major effort to help researchers learn more about various
diseases like Parkinson's and diabetes, Apple announced earlier this
week its vision for collecting data from patients via iPhone. Because
the device is sensor-laden and is usually kept in a pocket, data isn't
collected every three or so months like in many research trials; the
tool will update with new information every few seconds.
ResearchKit,
which is what the tool is called, works with Apple's existing HealthKit
platform. Patients with certain conditions can opt in to participate in
various clinical studies and surveys (daily, weekly, monthly and so on)
that can be evaluated and analyzed by medical researchers. The goal is
to ultimately improve patients' health and the ability to care for them.
ResearchKit
was probably the biggest surprise coming out of the Apple event," Scott
Snyder, president and chief strategy officer at mobile engagement
provider at Mobiquity told Mashable. "Other than working with HealthKit
parters like the Mayo Clinic for HealthKit, Apple has shied away from
getting involved with healthcare. But ResearchKit opens up the
possibility of data from 700 million iOS devices to be mined for
patterns and behaviors that create a whole new world for healthcare
research."
Those
possibilities, in theory, could be a huge step forward for the medical
field. For example, researchers could potentially determine if those who
live in higher-noise areas are more susceptible to stress-related
illnesses or even seizures, and if diet and activity have a significant
impact on tremors or flare-ups in certain disease areas, Snyder
suggested.
we
will have a massive living laboratory to answer some of these key
questions, especially when the lifestyle data can be merged with
longitudinal health data."
A
series of activities might include tapping different parts of the
iPhone's touchscreen to gauge response rate, multitasking skills and
more, as well as voice tests like saying "ahh" into the microphone. The
studies will mostly take advantage of the iPhone's built-in sensors to
collect this type of data.
It
could also serve as a powerful tool by bringing studies to people in
geographic locations where data collection is not typically conducted.
Partnerships
Partnerships
Mount
Sinai’s Icahn School of Medicine in New York City is one of Apple's
early partners for ResearchKit. The institution is bringing its Asthma
Health app (by tech startup LifeMap Solutions), which helps asthma
patients manage their condition, to the platform.
After
joining the study, verifying eligibility and signing a consent form,
asthma patients can access the app daily to monitor their condition. The
app then alerts users of environmental risk factors and medication
adherence. It also offers an e-diary for tracking symptoms and
educational content to increase awareness and insight into their
disease.
"The
goal is that app users will experience less asthma-related distress
with better symptom control, improved quality of life and fewer
unexpected medical visits by helping them take charge of their own
health," said Corey Bridges, CEO of LifeMap Solutions. "By keeping an
eye on how patients are using the app to varying degrees of success,
Mount Sinai will be able to assess the exact impact that such apps can
have as part of a regular treatment plan."
Bridges
said Apple and Mount Sinai started talking about the potential of
ResearchKit last June — nearly nine months before the platform's
arrival.
"It’s
one thing for an app to keep track of how far you’ve run or how many
calories you’ve burned, but another for a new platform to combine
various health data sources to analyze a holistic view of health for
patients self-managing chronic conditions," Bridges said. "We will
release separate apps that function as an intelligent health and
wellness coach that leverages cutting-edge medical and behavioral
research."
Because
Apple's platform is open-source, developers can continue to build onto
the platform. So far, partners include Penn Medicine at the University
of Pennsylvania, the University of Oxford, Xuanwu Hospital of Capital
Medical University in China and Stanford University.
After six hours we have 7406 people enrolled in our Parkinson's study. Largest one ever before was 1700 people. #ResearchKit
— John Wilbanks (@wilbanks) March 10, 2015
— John Wilbanks (@wilbanks) March 10, 2015
And
participation adoption rates are soaring. According to John Wilbanks of
Stanford University, nearly 7,500 people enrolled in the school's
Parkinson's study just six hours after ResearchKit was announced.
Previously, the largest pool of participants was 1,700.
Concerns
Concerns
Privacy
is unquestionably a major issue at play with ResearchKit. Apple said
during its event on Monday that data would be submitted anonymously and
never be seen by Apple. Users would have to opt in to sharing their
personal information.
Security practices will be key to ResearchKit's success.
Participants don't want to have their personal health information hacked, exposed and traced back to them.
For
some, like Andrew Flanagan, CEO of Telcare — an online service which
helps track conditions like diabetes — Apple's entrance into this space
is walking a murky line when it comes to ethics.
"While
this type of thinking is what’s needed to create a new era of digital
healthcare, issues concerning security, FDA clearance, and the ability
for health providers and patients to receive, communicate and act on the
data captured in near real-time are all challenges that need to be
addressed in order for these new technologies to have a meaningful
impact on individual health," he said.
"Apple's
ambitions are lofty and we've already seen the company pull back the
reins on what it had initially planned [for the Apple Watch]. Going that
deep into electrocardiogram-like heart-health monitoring and reporting,
for example, is too complicated for most companies, even Apple. Most
don't want to deal with the red tape and various regulatory issues."
But
Michael V. McConnell, professor of cardiovascular medicine at Stanford,
said the responsibility is more on those conducting the studies and not
Apple.
"Apple
has helped develop a platform to facilitate phone/mobile medical
research, but the primary ethical responsibility is with the
institutions designing and overseeing the studies, and their faculty and
institutional review boards (IRBS)," he said.
McConnell
added that Stanford is taking serious steps to make sure all data sent
and collected via the app is private and secure.
"Data
for these apps are sent encrypted from the phone app to a secure sever
run by Sage Bionetworks, a non-profit which has experience supporting
medical research studies and handling anonymized data servers for
analysis," he said. "The personal information is separated from the
research study data, so the secure server where the study data is stored
for analysis is anonymized."
Because
the technology is so new, there will undoubtedly be a learning curve,
from both the patient and researcher standpoint. McConnell said Stanford
will be looking at "feedback from participants and researchers to make
these tools and this type of research better."
Apple CEO says there's no business model behind ResearchKit. We're not in it for the ROI.
— Philip Elmer-DeWitt (@philiped) March 10, 2015
Apple says ResearchKit isn't about turning a profit, but rather on making the iPhone a greater asset to the medical community.
While it's uncertain as of now how powerful of a tool ResearchKit will become, it has true potential to be a game changer.
Posted by : Gizmeon
No comments:
Post a Comment